Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825 Conference

Hall, WA, Pugh, SL, Gilbert, MR et al. (2015). Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(3), S110-S110. 10.1016/j.ijrobp.2015.07.2257

cited authors

  • Hall, WA; Pugh, SL; Gilbert, MR; Wefel, JS; Armstrong, T; Wendland, MM; Brachman, DG; Roof, KS; Brown, PD; Crocker, IR; Robins, HI; Lee, RJ; Chao, ST; Kim, L; Srkalovic, G; Fisch, BM; Mehta, MP; Curran, WJ; Movsas, B

authors

date/time interval

  • October 18, 2015 -

publication date

  • November 1, 2015

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • San Antonio, TX

Digital Object Identifier (DOI)

Conference

  • 57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S110

end page

  • S110

volume

  • 93

issue

  • 3